Monitoring of hepatic function during amiodarone therapy.
Pollak
P Timothy
PT
Department of Medicine, Dalhousie University, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada. amiokinetics@hotmail.com
You
Yong Dong
YD
D000284:Administration, Oral; D000368:Aged; D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D000704:Analysis of Variance; D056486:Chemical and Drug Induced Liver Injury; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D011336:Probability; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
D000638:Amiodarone